To test this hypothesis, we treated astrocytes and explants of human IDH-WT glioblastoma with the FAS inhibitor Cerulenin (5 mg/ml) and measured gene expression using the PLATE-seq RNAseq (Fig. 9a). Here, FAS is linked to glioblastoma.